Keymed Biosciences Inc. (HKG: 2162)
Hong Kong
· Delayed Price · Currency is HKD 30.30
+0.60 (2.02%)
Jan 24, 2025, 4:08 PM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 8.13 billion as of January 30, 2025. Its market cap has decreased by -28.85% in one year.
Market Cap
8.13B
Enterprise Value
6.17B
Revenue
87.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.30
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has decreased from 18.43B to 8.13B, a decrease of -55.88%. That is a compound annual growth rate of -20.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2025 | 8.13B | -4.53% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.77% |
| Dec 30, 2022 | 14.27B | 47.83% |
| Dec 31, 2021 | 9.65B | -47.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 188.24B |
| Hansoh Pharmaceutical Group Company | 106.11B |
| JD Health International | 102.51B |
| WuXi Biologics | 75.46B |
| Sinopharm Group | 64.13B |
| Alibaba Health Information Technology | 58.05B |
| Akeso | 54.62B |
| Innovent Biologics | 54.14B |